Why the study?
Do Framingham and SCORE risk scores better predict coronary atherosclerosis and cardiovascular events compared to PROCAM and Diamond Forrester in patients with stable chest pain?
Do Framingham and SCORE risk scores better predict coronary atherosclerosis and cardiovascular events compared to PROCAM and Diamond Forrester in patients with stable chest pain?
No takes yet. Share an insight, caveat, or question.
FRS and SCORE are superior to PROCAM and Diamond Forrester for predicting significant CAD in stable chest pain patients, with FRS being the safest for identifying low-risk patients prior to CCTA.
Versteylen et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: